10-K Filing

Astrana Health, Inc. CIK: 1083446 FY 2020

Filing Information

Form Type	10-K
Accession Number	`0001628280-21-004679`
Period End Date	20201231
Filing Date	20210315
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	ameh-20201231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 104 Income Statement 117 Cash Flow Statement 212 Stockholders Equity 34

Balance Sheet 104 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$103.19M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$106.89M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$193.47M	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	-	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$75.00K	USD	Point-in-time
Investment in marketable securities	`MarketableSecuritiesCurrent`	$116.54M	USD	Point-in-time
Investment in marketable securities	`MarketableSecuritiesCurrent`	$67.69M	USD	Point-in-time
Receivables, net	`AccountsReceivableNetCurrent`	$7.06M	USD	Point-in-time
Receivables, net	`AccountsReceivableNetCurrent`	$11.00M	USD	Point-in-time
Receivables, net related parties	`AccountsReceivableRelatedPartiesCurrent`	$48.14M	USD	Point-in-time
Receivables, net related parties	`AccountsReceivableRelatedPartiesCurrent`	$49.26M	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$16.89M	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$4.30M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$10.31M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$16.75M	USD	Point-in-time
Loan receivable - short term	`NotesAndLoansReceivableNetCurrent`	$50.00K	USD	Point-in-time
Loan receivable - short term	`NotesAndLoansReceivableNetCurrent`	$22.93M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$329.07M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$338.58M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Land, property and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$29.89M	USD	Point-in-time
Land, property and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$12.13M	USD	Point-in-time
Treasury stock, common, shares (in shares)	`TreasuryStockCommonShares`	12.32M	shares	Point-in-time
Treasury stock, common, shares (in shares)	`TreasuryStockCommonShares`	17.46M	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$86.98M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$103.01M	USD	Point-in-time
Assets	`Assets`	$728.71M	USD	Point-in-time
Goodwill	`Goodwill`	$185.81M	USD	Point-in-time
Goodwill	`Goodwill`	$239.05M	USD	Point-in-time
Goodwill	`Goodwill`	$238.50M	USD	Point-in-time
Assets	`Assets`	$817.49M	USD	Point-in-time
Loans receivable	`NotesAndLoansReceivableNetNoncurrent`	-	USD	Point-in-time
Liabilities	`Liabilities`	$372.34M	USD	Point-in-time
Liabilities	`Liabilities`	$367.65M	USD	Point-in-time
Loans receivable	`NotesAndLoansReceivableNetNoncurrent`	$480.00K	USD	Point-in-time
Loans receivable related parties	`NotesReceivableRelatedPartiesNoncurrent`	$4.14M	USD	Point-in-time
Loans receivable related parties	`NotesReceivableRelatedPartiesNoncurrent`	-	USD	Point-in-time
Investments in other entities equity method	`EquityMethodInvestments`	$28.43M	USD	Point-in-time
Investments in other entities equity method	`EquityMethodInvestments`	$43.29M	USD	Point-in-time
Investments in privately held entities	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue`	$896.00K	USD	Point-in-time
Investments in privately held entities	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue`	$37.08M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$746.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$500.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$14.25M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$18.57M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.68M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$18.91M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$399.64M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$478.91M	USD	Point-in-time
Total assets	`Assets`	$728.71M	USD	Point-in-time
Total assets	`Assets`	$817.49M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$27.28M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$36.14M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$2.03M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$9.64M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$58.73M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$50.33M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$4.53M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$4.22M	USD	Point-in-time
Dividend payable	`DividendsPayableCurrent`	$271.00K	USD	Point-in-time
Dividend payable	`DividendsPayableCurrent`	$485.00K	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityCurrent`	$102.00K	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityCurrent`	$102.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.99M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$3.18M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$9.50M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$10.89M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$105.42M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$114.99M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$10.96M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$18.27M	USD	Point-in-time
Finance lease liabilities, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$311.00K	USD	Point-in-time
Finance lease liabilities, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$415.00K	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$11.37M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$15.87M	USD	Point-in-time
Long-term debt, net of current portion and deferred financing costs	`LongTermDebtNoncurrent`	$232.17M	USD	Point-in-time
Long-term debt, net of current portion and deferred financing costs	`LongTermDebtNoncurrent`	$230.21M	USD	Point-in-time
Total noncurrent liabilities	`LiabilitiesNoncurrent`	$257.35M	USD	Point-in-time
Total noncurrent liabilities	`LiabilitiesNoncurrent`	$262.23M	USD	Point-in-time
Total liabilities	`Liabilities`	$372.34M	USD	Point-in-time
Total liabilities	`Liabilities`	$367.65M	USD	Point-in-time
Commitments and Contingencies (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Noncontrolling interest in Allied Physicians of California, a Professional Medical Corporation ("APC")	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$114.24M	USD	Point-in-time
Noncontrolling interest in Allied Physicians of California, a Professional Medical Corporation ("APC")	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$168.72M	USD	Point-in-time
Common stock, par value $0.001; 100,000,000 shares authorized, 42,249,137 and 35,908,057 shares outstanding, excluding 12,323,164 and 17,458,810 treasury shares, at December 31, 2020 and 2019, respectively	`CommonStockValue`	$42.00K	USD	Point-in-time
Common stock, par value $0.001; 100,000,000 shares authorized, 42,249,137 and 35,908,057 shares outstanding, excluding 12,323,164 and 17,458,810 treasury shares, at December 31, 2020 and 2019, respectively	`CommonStockValue`	$36.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$261.01M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$159.61M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$69.77M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$31.91M	USD	Point-in-time
Stockholders' equity attributable to parent	`StockholdersEquity`	$191.55M	USD	Point-in-time
Stockholders' equity attributable to parent	`StockholdersEquity`	$330.82M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$786.00K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$87.00K	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$192.34M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$330.91M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$181.54M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$164.18M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders equity	`LiabilitiesAndStockholdersEquity`	$817.49M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders equity	`LiabilitiesAndStockholdersEquity`	$728.71M	USD	Point-in-time

Income Statement 117 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$165.17M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$95.76M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$156.06M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$519.91M	USD	Annual
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$176.78M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$180.12M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$178.75M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$687.18M	USD	Annual
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$560.62M	USD	Annual
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$130.05M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$165.10M	USD	1 Quarter
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServicesSold`	$361.13M	USD	Annual
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServicesSold`	$467.81M	USD	Annual
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServicesSold`	$539.21M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$49.12M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$43.35M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$41.48M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts`	$19.30M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts`	$18.28M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts`	$18.35M	USD	Annual
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$3.89M	USD	Annual
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$-1.36M	USD	Annual
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	-	USD	Annual
Impairment of goodwill and intangible assets	`GoodwillAndIntangibleAssetImpairment`	$3.80M	USD	Annual
Impairment of goodwill and intangible assets	`GoodwillAndIntangibleAssetImpairment`	-	USD	Annual
Impairment of goodwill and intangible assets	`GoodwillAndIntangibleAssetImpairment`	$1.99M	USD	Annual
Total expenses	`CostsAndExpenses`	$606.68M	USD	Annual
Total expenses	`CostsAndExpenses`	$528.20M	USD	Annual
Total expenses	`CostsAndExpenses`	$431.48M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$32.42M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$14.73M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$37.36M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$25.88M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$88.43M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$10.07M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$10.93M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$12.91M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$-3.31M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$80.50M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$4.37M	USD	1 Quarter
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$3.69M	USD	Annual
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-8.12M	USD	Annual
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-6.90M	USD	Annual
Interest expense	`InterestExpense`	$4.73M	USD	Annual
Interest expense	`InterestExpense`	$561.00K	USD	Annual
Interest expense	`InterestExpense`	$9.50M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$2.02M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$2.81M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$1.26M	USD	Annual
Gain on sale of equity method investment	`GainLossOnInvestments`	-	USD	Annual
Gain on sale of equity method investment	`GainLossOnInvestments`	$99.84M	USD	Annual
Gain on sale of equity method investment	`GainLossOnInvestments`	-	USD	Annual
Other income	`OtherNonoperatingIncomeExpense`	$1.62M	USD	Annual
Other income	`OtherNonoperatingIncomeExpense`	$3.03M	USD	Annual
Other income	`OtherNonoperatingIncomeExpense`	$1.08M	USD	Annual
Total other income (expense), net	`NonoperatingIncomeExpense`	$-5.80M	USD	Annual
Total other income (expense), net	`NonoperatingIncomeExpense`	$-6.58M	USD	Annual
Total other income (expense), net	`NonoperatingIncomeExpense`	$97.92M	USD	Annual
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$82.63M	USD	Annual
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$25.84M	USD	Annual
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$178.43M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$56.11M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$8.17M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$22.36M	USD	Annual
Net income	`ProfitLoss`	$60.27M	USD	Annual
Net income	`ProfitLoss`	$10.74M	USD	1 Quarter
Net income	`ProfitLoss`	$10.66M	USD	1 Quarter
Net income	`ProfitLoss`	$122.32M	USD	Annual
Net income	`ProfitLoss`	$81.00M	USD	1 Quarter
Net income	`ProfitLoss`	$17.67M	USD	Annual
Net income	`ProfitLoss`	$2.99M	USD	1 Quarter
Net income	`ProfitLoss`	$-2.45M	USD	1 Quarter
Net income	`ProfitLoss`	$12.91M	USD	1 Quarter
Net income	`ProfitLoss`	$25.42M	USD	1 Quarter
Net income	`ProfitLoss`	$-1.28M	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$49.43M	USD	Annual
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$3.56M	USD	Annual
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$84.45M	USD	Annual
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$3.54M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$10.84M	USD	Annual
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$7.04M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$6.73M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$4.05M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$3.70M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$14.12M	USD	Annual
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$16.71M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$10.06M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$37.87M	USD	Annual
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$140.00K	USD	1 Quarter
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	-	USD	1 Quarter
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.20	USD	1 Quarter
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.11	USD	1 Quarter
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.27	USD	1 Quarter
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.19	USD	1 Quarter
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$1.04	USD	Annual
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.41	USD	Annual
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.46	USD	1 Quarter
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.33	USD	Annual
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.11	USD	1 Quarter
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.10	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.10	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.26	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.11	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	-	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.19	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.45	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.39	USD	Annual
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.09	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.01	USD	Annual
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.29	USD	Annual
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.18	USD	1 Quarter
Weighted average shares of common stock outstanding basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	34.71M	shares	Annual
Weighted average shares of common stock outstanding basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	36.53M	shares	Annual
Weighted average shares of common stock outstanding basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	32.89M	shares	Annual
Weighted average shares of common stock outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.91M	shares	Annual
Weighted average shares of common stock outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.45M	shares	Annual
Weighted average shares of common stock outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	36.40M	shares	Annual

Cash Flow Statement 212 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$60.27M	USD	Annual
Net income	`ProfitLoss`	$10.74M	USD	1 Quarter
Net income	`ProfitLoss`	$10.66M	USD	1 Quarter
Net income	`ProfitLoss`	$122.32M	USD	Annual
Net income	`ProfitLoss`	$81.00M	USD	1 Quarter
Net income	`ProfitLoss`	$17.67M	USD	Annual
Net income	`ProfitLoss`	$2.99M	USD	1 Quarter
Net income	`ProfitLoss`	$-2.45M	USD	1 Quarter
Net income	`ProfitLoss`	$12.91M	USD	1 Quarter
Net income	`ProfitLoss`	$25.42M	USD	1 Quarter
Net income	`ProfitLoss`	$-1.28M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$18.28M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$19.30M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$18.35M	USD	Annual
Amortization of debt issuance cost	`AmortizationOfFinancingCosts`	$1.35M	USD	Annual
Amortization of debt issuance cost	`AmortizationOfFinancingCosts`	$473.00K	USD	Annual
Amortization of debt issuance cost	`AmortizationOfFinancingCosts`	-	USD	Annual
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-42.00K	USD	Annual
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-91.00K	USD	Annual
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	Annual
Impairment of goodwill and intangible assets	`GoodwillAndIntangibleAssetImpairment`	$3.80M	USD	Annual
Impairment of goodwill and intangible assets	`GoodwillAndIntangibleAssetImpairment`	-	USD	Annual
Impairment of goodwill and intangible assets	`GoodwillAndIntangibleAssetImpairment`	$1.99M	USD	Annual
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$3.89M	USD	Annual
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$-1.36M	USD	Annual
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	-	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$3.38M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$1.44M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$1.55M	USD	Annual
Gain on sale of equity method investment	`EquityMethodInvestmentRealizedGainLossOnDisposal`	-	USD	Annual
Gain on sale of equity method investment	`EquityMethodInvestmentRealizedGainLossOnDisposal`	-	USD	Annual
Gain on sale of equity method investment	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$99.84M	USD	Annual
Gain on loan assumption	`GainLossOnAssumptionOfLoan`	-	USD	Annual
Gain on loan assumption	`GainLossOnAssumptionOfLoan`	-	USD	Annual
Gain on loan assumption	`GainLossOnAssumptionOfLoan`	$2.25M	USD	Annual
Unrealized loss (gain) from investment in equity securities	`UnrealizedGainLossOnInvestments`	$-11.00K	USD	Annual
Unrealized loss (gain) from investment in equity securities	`UnrealizedGainLossOnInvestments`	$-25.00K	USD	Annual
Unrealized loss (gain) from investment in equity securities	`UnrealizedGainLossOnInvestments`	$9.00K	USD	Annual
(Income) loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$3.69M	USD	Annual
(Income) loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-8.12M	USD	Annual
(Income) loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-6.90M	USD	Annual
Deferred tax	`DeferredIncomeTaxesAndTaxCredits`	$-8.35M	USD	Annual
Deferred tax	`DeferredIncomeTaxesAndTaxCredits`	$-6.80M	USD	Annual
Deferred tax	`DeferredIncomeTaxesAndTaxCredits`	$-6.62M	USD	Annual
Receivables, net	`IncreaseDecreaseInAccountsReceivable`	$263.00K	USD	Annual
Receivables, net	`IncreaseDecreaseInAccountsReceivable`	$-4.13M	USD	Annual
Receivables, net	`IncreaseDecreaseInAccountsReceivable`	$-10.71M	USD	Annual
Receivables, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$28.36M	USD	Annual
Receivables, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$1.44M	USD	Annual
Receivables, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$1.12M	USD	Annual
Other receivables	`IncreaseDecreaseInOtherReceivables`	$15.08M	USD	Annual
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-12.59M	USD	Annual
Other receivables	`IncreaseDecreaseInOtherReceivables`	-	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$6.43M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$2.76M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$2.81M	USD	Annual
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseAssets`	$2.48M	USD	Annual
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseAssets`	$3.33M	USD	Annual
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseAssets`	-	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$5.53M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-2.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$572.00K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-22.67M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-4.88M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$8.20M	USD	Annual
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	-	USD	Annual
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$488.00K	USD	Annual
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$7.62M	USD	Annual
Capitation incentives payable	`IncreaseDecreaseInCapitationIncentivesPayable`	-	USD	Annual
Capitation incentives payable	`IncreaseDecreaseInCapitationIncentivesPayable`	-	USD	Annual
Capitation incentives payable	`IncreaseDecreaseInCapitationIncentivesPayable`	$-21.50M	USD	Annual
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$-8.69M	USD	Annual
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$-2.39M	USD	Annual
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$4.13M	USD	Annual
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$8.42M	USD	Annual
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-7.09M	USD	Annual
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-304.00K	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOtherOperatingLeaseLiabilities`	$-2.97M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOtherOperatingLeaseLiabilities`	$-2.24M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOtherOperatingLeaseLiabilities`	-	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$46.16M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$25.50M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$13.67M	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$115.40M	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$9.00K	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$1.79M	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$50.62M	USD	Annual
Proceeds from repayment of loans receivable - related parties	`ProceedsFromCollectionOfLongtermLoansToRelatedParties`	-	USD	Annual
Proceeds from repayment of loans receivable - related parties	`ProceedsFromCollectionOfLongtermLoansToRelatedParties`	$16.50M	USD	Annual
Proceeds from repayment of loans receivable - related parties	`ProceedsFromCollectionOfLongtermLoansToRelatedParties`	-	USD	Annual
Advances on loans receivable	`PaymentsToFundLongtermLoansToRelatedParties`	$7.50M	USD	Annual
Advances on loans receivable	`PaymentsToFundLongtermLoansToRelatedParties`	$145.00K	USD	Annual
Advances on loans receivable	`PaymentsToFundLongtermLoansToRelatedParties`	$11.43M	USD	Annual
Dividends received from equity method investments	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	$607.00K	USD	Annual
Dividends received from equity method investments	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	-	USD	Annual
Dividends received from equity method investments	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	$240.00K	USD	Annual
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	Annual
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	Annual
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$50.00K	USD	Annual
Payments for business acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$11.35M	USD	Annual
Payments for business acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Payments for business acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$49.40M	USD	Annual
Purchases of investments in privately held entities	`PaymentOfInvestmentPrivatelyHeldEntityDoesNotReportToNAVPerShare`	-	USD	Annual
Purchases of investments in privately held entities	`PaymentOfInvestmentPrivatelyHeldEntityDoesNotReportToNAVPerShare`	$405.00K	USD	Annual
Purchases of investments in privately held entities	`PaymentOfInvestmentPrivatelyHeldEntityDoesNotReportToNAVPerShare`	$491.00K	USD	Annual
Proceeds from sale of equity method investment	`ProceedsFromSaleOfEquityMethodInvestments`	$52.74M	USD	Annual
Proceeds from sale of equity method investment	`ProceedsFromSaleOfEquityMethodInvestments`	-	USD	Annual
Proceeds from sale of equity method investment	`ProceedsFromSaleOfEquityMethodInvestments`	-	USD	Annual
Purchases of investments equity method	`PaymentsToAcquireEquityMethodInvestments`	$9.97M	USD	Annual
Purchases of investments equity method	`PaymentsToAcquireEquityMethodInvestments`	$3.11M	USD	Annual
Purchases of investments equity method	`PaymentsToAcquireEquityMethodInvestments`	$16.71M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.16M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.04M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.17M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-25.18M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$95.49M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-180.63M	USD	Annual
Dividends paid	`PaymentsOfDividendsCommonStock`	$17.76M	USD	Annual
Dividends paid	`PaymentsOfDividendsCommonStock`	$61.72M	USD	Annual
Dividends paid	`PaymentsOfDividendsCommonStock`	$51.32M	USD	Annual
Repayments of debt	`RepaymentsOfLongTermDebt`	$2.38M	USD	Annual
Repayments of debt	`RepaymentsOfLongTermDebt`	-	USD	Annual
Repayments of debt	`RepaymentsOfLongTermDebt`	-	USD	Annual
Change in noncontrolling interest capital	`ProceedsFromPaymentsToMinorityShareholders`	-	USD	Annual
Change in noncontrolling interest capital	`ProceedsFromPaymentsToMinorityShareholders`	$28.00K	USD	Annual
Change in noncontrolling interest capital	`ProceedsFromPaymentsToMinorityShareholders`	$27.00K	USD	Annual
Borrowings on long-term debt	`ProceedsFromIssuanceOfOtherLongTermDebt`	$250.00M	USD	Annual
Borrowings on long-term debt	`ProceedsFromIssuanceOfOtherLongTermDebt`	$8.00M	USD	Annual
Borrowings on long-term debt	`ProceedsFromIssuanceOfOtherLongTermDebt`	-	USD	Annual
Borrowings on line of credit	`ProceedsFromLongTermLinesOfCredit`	-	USD	Annual
Borrowings on line of credit	`ProceedsFromLongTermLinesOfCredit`	$39.60M	USD	Annual
Borrowings on line of credit	`ProceedsFromLongTermLinesOfCredit`	-	USD	Annual
Repayments on bank loan and lines of credit	`RepaymentsOfBankLoanAndLinesOfCredit`	-	USD	Annual
Repayments on bank loan and lines of credit	`RepaymentsOfBankLoanAndLinesOfCredit`	$495.00K	USD	Annual
Repayments on bank loan and lines of credit	`RepaymentsOfBankLoanAndLinesOfCredit`	$52.64M	USD	Annual
Payment of capital lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$105.00K	USD	Annual
Payment of capital lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$99.00K	USD	Annual
Payment of capital lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$102.00K	USD	Annual
Proceeds from exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$4.00M	USD	Annual
Proceeds from exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$3.12M	USD	Annual
Proceeds from exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$10.80M	USD	Annual
Proceeds from common stock offering	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from common stock offering	`ProceedsFromIssuanceOfCommonStock`	$755.00K	USD	Annual
Proceeds from common stock offering	`ProceedsFromIssuanceOfCommonStock`	$200.00K	USD	Annual
Repurchase of common shares	`PaymentsForRepurchaseOfCommonStock`	$5.05M	USD	Annual
Repurchase of common shares	`PaymentsForRepurchaseOfCommonStock`	$537.00K	USD	Annual
Repurchase of common shares	`PaymentsForRepurchaseOfCommonStock`	$7.57M	USD	Annual
Distribution to noncontrolling interest	`PaymentsOfDividendsMinorityInterest`	$1.04M	USD	Annual
Distribution to noncontrolling interest	`PaymentsOfDividendsMinorityInterest`	-	USD	Annual
Distribution to noncontrolling interest	`PaymentsOfDividendsMinorityInterest`	-	USD	Annual
Cost of debt and equity issuances	`PaymentOfFinancingAndStockIssuanceCosts`	-	USD	Annual
Cost of debt and equity issuances	`PaymentOfFinancingAndStockIssuanceCosts`	$5.77M	USD	Annual
Cost of debt and equity issuances	`PaymentOfFinancingAndStockIssuanceCosts`	-	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$163.33M	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-51.70M	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-11.18M	USD	Annual
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$89.96M	USD	Annual
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-10.86M	USD	Annual
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.63M	USD	Annual
Cash, cash equivalents and restricted cash, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$193.97M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$118.50M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$107.64M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$104.01M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$193.97M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$118.50M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$107.64M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$104.01M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$23.64M	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	$20.20M	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	$62.00M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$462.00K	USD	Annual
Cash paid for interest	`InterestPaidNet`	$8.51M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$4.26M	USD	Annual
Cashless exercise of warrants	`CashlessExerciseOfStockOptions`	$599.00K	USD	Annual
Cashless exercise of warrants	`CashlessExerciseOfStockOptions`	-	USD	Annual
Cashless exercise of warrants	`CashlessExerciseOfStockOptions`	-	USD	Annual
Deferred tax liability adjusted to goodwill	`DeferredTaxLiabilityAdjustedToGoodwill`	-	USD	Annual
Deferred tax liability adjusted to goodwill	`DeferredTaxLiabilityAdjustedToGoodwill`	$6.33M	USD	Annual
Deferred tax liability adjusted to goodwill	`DeferredTaxLiabilityAdjustedToGoodwill`	$1.11M	USD	Annual
Reclassification of liability for equity shares	`ReclassificationOfLiabilityForEquity`	-	USD	Annual
Reclassification of liability for equity shares	`ReclassificationOfLiabilityForEquity`	$1.19M	USD	Annual
Reclassification of liability for equity shares	`ReclassificationOfLiabilityForEquity`	-	USD	Annual
Purchase price adjustment for acceleration of vested stock options	`PurchasePriceAdjustmentforAccelerationofVestedStockOptions`	$868.00K	USD	Annual
Purchase price adjustment for acceleration of vested stock options	`PurchasePriceAdjustmentforAccelerationofVestedStockOptions`	-	USD	Annual
Purchase price adjustment for acceleration of vested stock options	`PurchasePriceAdjustmentforAccelerationofVestedStockOptions`	-	USD	Annual
Conversion of loan receivable to investment in Accountable Health Care, IPA	`NoncashorPartNoncashAcquisitionConversionofLoanReceivabletoInvestmentInterest`	$5.00M	USD	Annual
Conversion of loan receivable to investment in Accountable Health Care, IPA	`NoncashorPartNoncashAcquisitionConversionofLoanReceivabletoInvestmentInterest`	-	USD	Annual
Conversion of loan receivable to investment in Accountable Health Care, IPA	`NoncashorPartNoncashAcquisitionConversionofLoanReceivabletoInvestmentInterest`	-	USD	Annual
Reclassification of dividends related to share repurchase	`ReclassificationOfDividendsRelatedToSharesRepurchase`	$4.22M	USD	Annual
Reclassification of dividends related to share repurchase	`ReclassificationOfDividendsRelatedToSharesRepurchase`	-	USD	Annual
Reclassification of dividends related to share repurchase	`ReclassificationOfDividendsRelatedToSharesRepurchase`	-	USD	Annual
Reclassification of APS noncontrolling interest to equity related to purchase of additional shares	`ReclassificationOfAPSNonControllingInterestToEquity`	-	USD	Annual
Reclassification of APS noncontrolling interest to equity related to purchase of additional shares	`ReclassificationOfAPSNonControllingInterestToEquity`	$2.83M	USD	Annual
Reclassification of APS noncontrolling interest to equity related to purchase of additional shares	`ReclassificationOfAPSNonControllingInterestToEquity`	-	USD	Annual
Deferred tax liability adjustment related to warrant exercises	`AdjustmentOfWarrantsGrantedForServices`	-	USD	Annual
Deferred tax liability adjustment related to warrant exercises	`AdjustmentOfWarrantsGrantedForServices`	-	USD	Annual
Deferred tax liability adjustment related to warrant exercises	`AdjustmentOfWarrantsGrantedForServices`	$690.00K	USD	Annual
Preferred shares received from sale of equity method investment	`ConversionOfStockAmountIssued1`	$36.18M	USD	Annual
Preferred shares received from sale of equity method investment	`ConversionOfStockAmountIssued1`	-	USD	Annual
Preferred shares received from sale of equity method investment	`ConversionOfStockAmountIssued1`	-	USD	Annual
Beneficial interest acquired from sale of equity method investment	`ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset`	$15.72M	USD	Annual
Beneficial interest acquired from sale of equity method investment	`ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset`	-	USD	Annual
Beneficial interest acquired from sale of equity method investment	`ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset`	-	USD	Annual
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$103.19M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$106.89M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$193.47M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$193.97M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$118.50M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$107.64M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$104.01M	USD	Point-in-time

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Balance at beginning	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$192.34M	USD	Point-in-time
Balance at beginning	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$330.91M	USD	Point-in-time
Balance at beginning	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$181.54M	USD	Point-in-time
Balance at beginning	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$164.18M	USD	Point-in-time
Net income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$15.87M	USD	Annual
Net income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$38.70M	USD	Annual
Net income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$12.38M	USD	Annual
Purchase price adjustment from Merger	`AdjustmentsToAdditionalPaidInCapitalMergerPurchasePriceAdjustment`	$868.00K	USD	Annual
Repurchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$7.29M	USD	Annual
Repurchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$301.00K	USD	Annual
Repurchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$-432.00K	USD	Annual
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$3.23M	USD	Annual
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$11.49M	USD	Annual
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$4.00M	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$632.00K	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.38M	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$940.00K	USD	Annual
Noncontrolling interest capital change	`NoncontrollingInterestIncreaseFromCapitalCharge`	$28.00K	USD	Annual
Noncontrolling interest capital change	`NoncontrollingInterestIncreaseFromCapitalCharge`	$28.00K	USD	Annual
Dividends	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$1.99M	USD	Annual
Dividends	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$1.98M	USD	Annual
Acquisition of additional shares in consolidated entity	`MinorityInterestDecreaseFromRedemptions`	-	USD	Annual
Reclassification of options liability to equity	`StockIssuedDuringPeriodValueStockOptionsLiabilityReclassifiedToEquity`	-	USD	Annual
Release of 50% holdback shares	`StockRepurchaseDuringPeriodValueReleaseOfHoldBackShares`	-	USD	Annual
Release of 50% holdback shares	`StockRepurchaseDuringPeriodValueReleaseOfHoldBackShares`	-	USD	Annual
Stock subscription	`StockIssuedDuringPeriodValueNewIssues`	-	USD	Annual
Shares issued in connection with business acquisition	`StockIssuedDuringPeriodValueAcquisitions`	-	USD	Annual
Cost of equity issuance of preferred shares	`AllocatedShareBasedCompensationExpenseNetOfTax`	-	USD	Annual
Cancellation of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures`	$236.00K	USD	Annual
Dividends	`NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares`	$85.54M	USD	Annual
Balance at ending	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$192.34M	USD	Point-in-time
Balance at ending	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$330.91M	USD	Point-in-time
Balance at ending	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$181.54M	USD	Point-in-time
Balance at ending	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$164.18M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.